CD192, Human (Plozalizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD192, Human (Plozalizumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD192, Human (Plozalizumab biosimilar)
ClonePlozalizumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsELISA, IHC, IF, IP, FCM, Inhib
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD192 Recombinant Antibody. Plozalizumab (INN, hu1D9) is a humanized monoclonal antibody designed for the treatment of diabetic nephropathy and arteriovenous graft patency. This drug was developed by Takeda Pharmaceuticals International Co.
Immunogenn/a
Other NamesAnti-CD192 Recombinant Antibody, Research Grade Plozalizumab, Anti-Human CD192 Recombinant Antibody, MLN-1202, anti-CCR2, hu1D9, Antibody Drug Analogues, Monoclonal Antibody, YR1384, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1610761-46-0
Catalog #YR1384
Priceplease inquire
Order / More InfoCD192, Human (Plozalizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.